Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples